Video Player is loading.
Current Time 0:00
Duration 1:28:29
Loaded: 0.00%
Stream Type LIVE
Remaining Time 1:28:29
1x

Media Error

An error occurred while trying to load the media. Please, try again later.

Try Again

Join MyPOC Academy, its free and courses are CPD accredited

JOIN

Presentations

  • item.name

    Prof. Nicholas Francis
    (England)
    Chair

  • item.name

    Prof. Ivan Gentile
    (Italy)
    Speaker

    Severity assessment and outcome prediction in the COVID-19 patients

  • item.name

    Dr. Carl Llor
    (Spain)
    Speaker

    The emergence of multi-resistance associated with the overuse of antibiotics during COVID-19 pandemic

  • item.name

    Prof. Dag Berild
    (Norway)
    Speaker

    Antimicrobial stewardship in the time of COVID-19 is vital — AMR still persists and could be height

  • item.name

    Dr. Aggy York
    (England)
    Panelist

    Panel Discussion: CRP and Point of Care testing — knowledge sharing from across Europe

Join MyPOC Academy, its free and courses are CPD accredited

JOIN

Background

Join a panel of experts from across Europe for this compelling webinar presenting a view from the front line in Europe.

The webinar will analyse studies from around the world that show that C-reactive protein (CRP) levels proved to be one of the strongest inflammatory markers for severity and risk assessment in COVID-19 patients. [1] [2] [3] [4] [5]

The webinar will highlight the importance of Antibiotic Stewardship Programs (ASPs) in the context of the global pandemic and how antibiotics should be used only when necessary to curb the rise of antimicrobial resistance (AMR). [6] [7] [8] [9]

90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing. [10]

Learning Outcomes

  • Despite the viral origin of COVID-19, a standard reflex by physicians is to start treatment with antibiotics since cough, fever and radiologic infiltrates are hallmarks of bacterial community-acquired pneumonia, which requires antibiotic treatment. [9]
  • The detection of CRP is of certain value to distinguish whether there is a bacterial infection in the lung. [6]
  • CRP may reflect disease severity and may be an independent predictor of adverse outcomes in COVID-19 patients. [1] [2] [3] [4] [5]
  • Antibiotics should be reserved for the patients with the most severe presentations. [9]
  • Avoid blind or inappropriate use of antibacterial drugs, especially the combination of broad-spectrum antibacterial drugs. [6]
  • There are many reasons why European countries launch Antibiotic Stewardship Programs (ASPs), and in the context of COVID-19, an ASP is needed now more than ever.

About MYPOCACADEMY

Professional Blended Learning Continuum

  • MyPOCAcademy is an interactive educational resource providing information on the rationale for Point of Care Testing testing and its value, across a number of medical specialities.
  • The courses will allow you to enhance your knowledge and skills at your own pace.
  • CME-accredited materials and webinars will be available shortly

Assess Your Understanding

  • Within each course are test questions that allow you to test your knowledge.
  • Interactive patient case studies enable you to view the benefits of Point of Care Testing in real-life clinical scenarios

Convenient Access to Latest POC Information

  • MyPOCAcademy is your go-to resource for the latest information related to Point of Care Testing.
  • Learning can be accessed at your convenience with the click of a button.
Video Player is loading.
Current Time 0:00
Duration 2:00
Loaded: 17.77%
Stream Type LIVE
Remaining Time 2:00
1x

Media Error

An error occurred while trying to load the media. Please, try again later.

Try Again
  1. CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). April 3, 2020. — https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidancemanagement-patients.html#lab-findings
  2. Luo X, et al. medRxiv. Published online 2020. — https://doi.org/10.1101/2020.03.21.20040360
  3. Tan C, et al. ORCID iD: 0000-0002-2522-4524.
  4. Wang L. Médecine et maladies infectieuses. 2020. — https://doi.org/10.1016/j.medmal.2020.03.007
  5. Li H, et al. Journal of Infection. Published online 2020. — https://doi.org/10.1016/j.jinf.2020.03.035
  6. Huttner B, et al. COVID-19: Don’t neglect antimicrobial stewardship: principles! Clinical Microbiology and Infection. 2020. — https://doi.org/10.1016/j.cmi.2020.04.024
  7. Guan W, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi:10.1056/NEJMoa2002032
  8. Rawson T, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;2:ciaa530. doi:10.1093/cid/ciaa530.32358954
  9. Jin YH, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 2020;7:4. — https://doi.org/10.1186/s40779-020-0233-6
  10. Aabenhus R, et al. Cochrane Database of Systematic Reviews. 2014;11. Art. No.: CD010130.

Join MyPOC Academy, its free and courses are CPD accredited

JOIN